Myocardial “bridging” (MB) is an entity known for more than 200 years. However, the
frequency of MB-and still is unknown, we do not know whether the MB is hereditary or
not, what is its clinical significance; there are no guidelines on how to diagnose it, and
whether it should be and how to treat.
The aim of this investigation was to determine the frequency of MB-a in patients with
clinically suspected coronary artery disease and assess the clinical significance of MB
based on MSCT coronary angiography, to investigate the relationship of the clinical
finding with the characteristics of MB and the possible impact on future therapeutic
strategy and future guidelines of the MB